Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma.
Budde A, Baust K, Weinhold L, Bernstein M, Bielack S, Dhooge C, Hjorth L, Janeway KA, Jenney M, Krailo MD, Marina N, Nagarajan R, Smeland S, Sydes MR, De Vos P, Whelan J, Wiener A, Calaminus G, Schmid M. Budde A, et al. Among authors: bielack s. Eur J Cancer. 2022 Jul;170:209-235. doi: 10.1016/j.ejca.2022.03.018. Epub 2022 Jun 8. Eur J Cancer. 2022. PMID: 35689897 Free PMC article.
Osteosarcoma over the age of forty.
Grimer RJ, Cannon SR, Taminiau AM, Bielack S, Kempf-Bielack B, Windhager R, Dominkus M, Saeter G, Bauer H, Meller I, Szendroi M, Folleras G, San-Julian M, van der Eijken J. Grimer RJ, et al. Among authors: bielack s. Eur J Cancer. 2003 Jan;39(2):157-63. doi: 10.1016/s0959-8049(02)00478-1. Eur J Cancer. 2003. PMID: 12509946
Periosteal osteosarcoma--a European review of outcome.
Grimer RJ, Bielack S, Flege S, Cannon SR, Foleras G, Andreeff I, Sokolov T, Taminiau A, Dominkus M, San-Julian M, Kollender Y, Gosheger G; European Musculo Skeletal Oncology Society. Grimer RJ, et al. Among authors: bielack s. Eur J Cancer. 2005 Dec;41(18):2806-11. doi: 10.1016/j.ejca.2005.04.052. Epub 2005 Nov 14. Eur J Cancer. 2005. PMID: 16290134
Osteosarcoma: the same old drugs or more?
Bielack SS, Marina N, Ferrari S, Helman LJ, Smeland S, Whelan JS, Reaman GH. Bielack SS, et al. J Clin Oncol. 2008 Jun 20;26(18):3102-3; author reply 3104-5. doi: 10.1200/JCO.2008.17.1108. J Clin Oncol. 2008. PMID: 18565904 No abstract available.
The role of interferons in the treatment of osteosarcoma.
Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, Bernstein M. Whelan J, et al. Among authors: bielack s. Pediatr Blood Cancer. 2010 Mar;54(3):350-4. doi: 10.1002/pbc.22136. Pediatr Blood Cancer. 2010. PMID: 19902521 Review.
Osteosarcoma: the COSS experience.
Bielack S, Jürgens H, Jundt G, Kevric M, Kühne T, Reichardt P, Zoubek A, Werner M, Winkelmann W, Kotz R. Bielack S, et al. Cancer Treat Res. 2009;152:289-308. doi: 10.1007/978-1-4419-0284-9_15. Cancer Treat Res. 2009. PMID: 20213397 Review.
Osteosarcoma: time to move on?
Bielack SS. Bielack SS. Eur J Cancer. 2010 Jul;46(11):1942-5. doi: 10.1016/j.ejca.2010.03.009. Epub 2010 Apr 10. Eur J Cancer. 2010. PMID: 20385483 No abstract available.
266 results